Achieve Life Sciences, Inc.
Veridion Score
Composite trend over time
Why is ACHV moving today?
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ACHV.
ACHV insider activity
Achieve Life Sciences, Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for ACHV.
ACHV contract awards, year to date.
Public federal awards linked to this ticker.
ACHV lobbying filings, year to date.
Registered lobbying filings matched to Achieve Life Sciences, Inc..